Clinical Characteristics and Prognosis of AIDS Complicated with Talaromycosis marneffei Infection: a Single-Center Retrospective Study
Open Access
- 23 July 2025
- journal article
- research article
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 14 (8) , 1935-1952
Abstract
Introduction The objective of the study was to determine the clinical features and prognostic risk factors of acquired immunodeficiency syndrome (AIDS) combined with Talaromyces marneffei (TM) infection. Methods We retrospectively analyzed the clinical data of 133 hospitalized patients diagnosed with AIDS and TM co-infection. Patients were divided into an improvement group and a deterioration group on the basis of their discharge outcomes. To further investigate the severity of adverse outcomes, subgroup analysis was performed on the deterioration group. Due to the issue of complete separation in the data, Firth’s logistic regression model was employed to identify independent prognostic factors. Finally, the predictive performance of the model was evaluated using the receiver operating characteristic (ROC) curve. Results Among 133 patients with AIDS and TM co-infection, the main manifestations were fever (93.23%) and severe immunodeficiency with median CD4+ T cell count of 8.50 cells/μL, with blood culture showing the highest positive rate (93.85%). Firth’s logistic regression analysis revealed that timely antifungal therapy (OR 0.004, 95% CI P < 0.001) and higher baseline albumin (ALB) levels (OR 0.858, 95% CI 0.732–0.973, P = 0.016) were independent protective factors for improving patient prognosis. The area under the receiver operating characteristic (ROC) curve (AUC) of the model was 0.930 (95% CI 0.878–0.982). Conclusions Timely antifungal therapy and good nutritional status are key determinants of prognosis in patients with AIDS and TM co-infection. Early diagnosis, prompt initiation of effective treatment, and active nutritional support are of great significance for improving patient survival outcomes.Keywords
Funding Information
- The National Natural Science Foundation of China (82370604)
- the Major Science and Technology innovation Project of Fujian Province (2023Y9269)
- the Natural Science Foundation of Fujian Province (2023J01239)
This publication has 25 references indexed in Scilit:
- Characteristics of Endemic Mycoses Talaromyces marneffei Infection Associated with Inborn Errors of ImmunityJournal of Clinical Immunology, 2024
- Talaromyces marneffei suppresses macrophage inflammation by regulating host alternative splicingCommunications Biology, 2023
- Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency SyndromeMycopathologia, 2022
- Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic MycosisMycopathologia, 2021
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guidelineClinical Microbiology and Infection, 2018
- Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patientsExpert Review of Clinical Pharmacology, 2017
- Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and TalaromycosisCurrent Infectious Disease Reports, 2017
- HypoalbuminemiaInternal and Emergency Medicine, 2012
- Cell-mediated immunity in host resistance against infection caused byPenicillium marneffeiMedical Mycology, 1996
- Disseminated Penicillium marneffei infection in Southeast AsiaThe Lancet, 1994